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INTRODUCTION
Monosomy 7 or partial loss of 7q is found in 30% of children
with myeloid disorders and is characterized by ineffective
hematopoiesis, dysplastic bone marrow, and risk of evolution into
acute leukemia [1]. Children with inherited bone marrow failure
syndromes (IBMFS) are predisposed to myelodysplastic syndrome
(MDS). One such IBMFS is dyskeratosis congenita (DC), a disorder
that classically presents with bone marrow dysfunction and
mucocutaneous features (abnormal pigmentation, dystrophic nails,
and oral leukoplakia) [2]. Many patients with DC, however, lack
the classic mucocutaneous features and have other somatic
abnormalities such as lung disease, esophageal stricture, liver
cirrhosis, osteoporosis, genitourinary anomalies, and cerebellar
hypoplasia [2]. Mutations in six different genes (DKC1, NOP10,
NHP2, TERC, TERT, and TINF2) cause DC, but account for
only half of the patients diagnosed with this disorder [2,3]. Five of
these genes (DKC1, NOP10, NHP2, TERC, and TERT) encode
components of the telomerase complex. The sixth gene mutated in
DC, TINF2, encodes a protein component (TIN2) of the telomere
ribonucleoprotein complex shelterin that safeguards telomeres [4].
The finding that all known genes affected in DC are involved
in telomere maintenance suggests that telomere dysfunction
plays a central role in the pathogenesis of DC and possibly other
IBMFS [5,6].
We describe a male with acquired monosomy 7 MDS and
manifestations of DC who underwent successful allogeneic
hematopoietic stem cell transplantation (HSCT). Interestingly, this
patient also has congenital adrenal insufficiency and other features
of the rare, presumably autosomal recessive, endocrine disorder
IMAGe association [intrauterine growth retardation (IUGR),
metaphyseal dysplasia, adrenal hypoplasia congenita, genital
anomalies; OMIM 300290] [7–13]. The genital anomalies of
IMAGe association, which are restricted to males, include
micropenis, hypospadias, cryptorchidism, and bifid scrotum [13].
Individuals with IMAGe association also have craniofacial
anomalies (e.g., frontal bossing, broad nasal bridge, and low-set
ears) [7–13]. Skin hyperpigmentation, reminiscent of that found in
DC, has also been reported in IMAGe association [8]. The genetic
basis of IMAGe association is unknown, although mice harboring a
mutation in another telomere maintenance gene, Tpp1, have adrenal
hypoplasia congenita and other hallmarks of this disorder [14,15].
We considered the possibility that this patient may have defective
telomere function resulting in features of both DC and IMAGe
association.
CASE REPORT
The Caucasian male was born at 32 weeks gestational age to non-
consanguinous parents. The family history was unremarkable. The
pregnancy was complicated by placenta previa and IUGR. Delivery
was via caesarian section. APGAR scores were 7 at 1 min and 8 at
5 min, and the birth weight was 1,157 g. As a neonate, he was noted
to have bifrontal bossing, broad nasal bridge, low-set ears (Fig. 1A),
and genital anomalies (microphallus, hypospadias, and bilateral
cryptorchidism). Chromosome analysis revealed a 46,XY genotype.
He received testosterone replacement therapy with a good response
in phallic and testicular enlargement and underwent orchiopexy to
correct his cryptorchidism.
In the first week of life he developed hyponatremia and
hyperkalemia. Endocrinologic evaluation revealed an elevated
plasma adrenocorticotrophic hormone level with a low plasma
cortisol level at less than 0.7 mg/dl (normal range 4–22 mg/dl) and
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normal plasma 17-hydroxyprogesterone level at 40 (normal range
26–568) resulting in the diagnosis of adrenal hypoplasia congenita.
A co-syntropin stimulation test at 20 days of age revealed a baseline
cortisol level of <0.7 mg/dl and a stimulation level of 3.2 mg/dl,
supporting the diagnosis of primary adrenocortical insufficiency.
As a toddler he had feeding difficulties due to uncoordinated
swallowing and esophageal stricture. He underwent esophagoscopy
with dilation at 2 and 4 years of age. Esophageal biopsy showed
ballooning degeneration of the squamous epithelium. Despite
adequate caloric intake, his weight and length remained
<3rd percentile throughout childhood. At the chronologic age of
4.3 years, his bone age was 3.7 years. MRI of his brain at 16 months
of age showed a large extracerebral cerebrospinal fluid space in his
left frontal region and multiple diffuse periventricular white matter
lesions with abnormal myelination. Extensive genetic testing was
performed on the patient, and the results are summarized in Table I.
As an infant and toddler he had numerous hospitalizations for
recurrent pneumonia. Chest radiographs and computed tomography
of the chest showed diffuse bilateral ground glass opacities
superimposed on bronchiectasis and bronchiolectasis (Fig. 1B).
Bronchoscopy revealed a normal tracheal lining, increased mucosal
vascularity, and thick, clear secretions throughout the bronchial tree.
Biopsy of the respiratory epithelium demonstrated normal cilia on
electron microscopy. In addition to lung infections, he had frequent
episodes of otitis media with associated hearing loss, necessitating
myringotomies with tympanostomy tube placement. An immuno-
deficiency workup revealed a low Haemophilus influenzae titer and
low IgG for which he received intravenous immunoglobulin
replacement therapy.
At 3 years of age, he developed persistent neutropenia. Bone
marrow evaluation revealed myeloid hyperplasia with atypia,
neutrophil hypolobation, and hypergranulation. Cytogenetic anal-
ysis revealed monosomy 7 in 18 of 20 metaphases. FISH analysis
of buccal mucosal cells and fibroblasts revealed no monosomy 7.
With written informed consent of the parents and approval of the
Institutional Review Board, peripheral blood mononuclear cell
(PBMC) telomere length measurements [16] were performed on the
patient and his family (Fig. 1C). There was no telomere shortening
present in either the patient or his parents. A series of telomere
maintenance genes were also sequenced (TERC, TERT, TINF2,
TPP1, and DKC1), but no mutations were detected.
At 6 years of age, he underwent allogenic HSCT from a 10/10
allele matched unrelated donor. The preparative regimen included
fludarabine 120 mg/m2 and melphalan 140 mg/m2 [17]. Graft-
versus-host disease (GVHD) prophylaxis included methotrexate,
cyclosporine A, and prednisone. He tolerated HSCT without acute
complications. A skin rash developed 8 months after transplant
and was consistent with GVHD restricted to the skin. Topical
hydrocortisone induced minimal improvement but therapeutic
levels of cyclosporine (250–350 ng/ml) induced remission with
residual localized hyperpigmentation. Mucus membranes and other
organs remained unaffected and cyclosporine was weaned again
Pediatr Blood Cancer DOI 10.1002/pbc
Fig. 1. A: Picture of the patient at 5 years of age. Note the disproportionately large head, prominent forehead, broad nasal bridge, low-set ears, and
thin arms. The physical appearance of our patient resembles that of individuals with IMAGe association [10]. B: Computed tomography of the chest
at 4 years of age showing extensive pulmonary disease with bronchiectasis and tree-in-bud infiltrates bilaterally. C: PBMC telomere length
measurements on the proband and his unaffected first degree relatives. Lines represent percentiles (1–99%) of telomere length measured in
234 healthy individuals between the ages of 0.3 and 94 years old. Red circles indicate the telomere lengths for proband and his relatives. The proband
is indicated as 289.1, mother as 289.2, father as 289.3, and sibling as 289.4. All family members had normal telomere lengths. [Color figure can be
viewed in the online issue, which is available at www.interscience.wiley.com.]
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gradually. Complete donor engraftment with no evidence of
monosomy 7 was documented at 1 year.
In the post-transplant period, he developed several lower
respiratory infections, likely secondary to immunosuppression
and underlying bronchiectasis. Accordingly, he was maintained
on alternating courses of levofloxacin and ciprofloxacin prophylaxis
until 1 year post-transplant, and monthly infusions of intravenous
immunoglobulin therapy (400 mg/kg/dose) for 15 months.
DISCUSSION
Although he lacked the classic mucocutaneous features of
DC, the proband had other hallmarks of DC including IUGR,
MDS, esophageal stricture, lung disease, and hypospadias. DC is
a telomere maintenance disorder and is often, but not always,
associated with very short telomeres [16]. Although the PBMC
telomere length was normal, this was measured after the diagnosis
of MDS, and the surviving MDS hematopoietic cells may not have
reflected the average telomere length in other tissues. For this reason
telomere length measurements must be interpreted with caution
[16]. He did not harbor a mutation in TERC, TERT, DKC1, or TINF2,
but only about half of patients with DC have an identifiable mutation
in these telomere maintenance genes.
A cardinal finding in our patient, congenital adrenal insuffi-
ciency, has not been linked to DC in humans. However, mice har-
boring a hypomorphic allele of Tpp1, a component of the shelterin
complex that protects telomeres, exhibit a complex phenotype that
includes adrenocortical hypoplasia with cytomegaly [14,15]. This
allele, termed Tpp1acd (for the adrenocortical dysplasia strain),
results in telomeres that are dysfunctional, leading to an increase
in senescence-associated markers in adrenocortical cells. These
findings suggest that Tpp1 is essential for proper function of
progenitor cells in the adrenal cortex and that abnormalities in
telomere maintenance can, at least in mice, manifest as adrenocort-
ical dysfunction. Investigators are currently searching for mutations
in telomere maintenance genes in humans with certain forms of
congenital adrenocortical insufficiency [7,18,19]. We did not detect
a TPP1 mutation in our patient.
One other patient with monosomy 7 syndrome, congenital
adrenal hypoplasia with cytomegaly, and male pseudohermaphro-
ditism has been previously described by Le and Kutteh [20]. We
speculate that our patient and that of Le and Kutteh have a still
undefined defect in telomere function with features of both DC
and IMAGe association. Clinically well-delineated cases such
as these may help elucidate the molecular pathogenesis of MDS
and telomere maintenance disorders. While the hematopoietic
manifestations of MDS and monosomy 7 were successfully tackled
in our patient with reduced intensity allogeneic HSCT, other
systemic manifestations such as adrenal and pulmonary complica-
tions continue to require ongoing management.
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